Accessibility Menu
Ardelyx logo

Ardelyx

(NASDAQ) ARDX

Current Price$6.20
Market Cap$1.53B
Since IPO (2014)-56%
5 Year-21%
1 Year+70%
1 Month+1%

Ardelyx Financials at a Glance

Market Cap

$1.53B

Revenue (TTM)

$427.68M

Net Income (TTM)

-$58.06M

EPS (TTM)

-$0.24

P/E Ratio

-25.94

Dividend

$0.00

Beta (Volatility)

0.89 (Low)

Price

$6.20

Volume

2,878,747

Open

$6.28

Previous Close

$6.19

Daily Range

$6.15 - $6.38

52-Week Range

$3.56 - $8.40

Estimated Earnings Date

Aug 3, 2026

ARDX: Motley Fool Moneyball Superscore

66

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ardelyx

Industry

Biotechnology

Employees

489

CEO

Mike Raab

Headquarters

Waltham, MA 02451, US

ARDX Financials

Key Financial Metrics (TTM)

Gross Margin

91.93%

Operating Margin

-8.75%

Net Income Margin

-13.58%

Return on Equity

-38.11%

Return on Capital

-10.82%

Return on Assets

-11.51%

Earnings Yield

-3.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.53B

Shares Outstanding

247.03M

Volume

2.88M

Avg. Volume

3.63M

Financials (TTM)

Gross Profit

$393.18M

Operating Income

-$37.42M

EBITDA

-$25.52M

Operating Cash Flow

-$36.26M

Capital Expenditure

-$1.24M

Free Cash Flow

-$37.50M

Cash & ST Invst.

$238.07M

Total Debt

$208.26M

Ardelyx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$94.47M

+27.5%

Gross Profit

$89.66M

+46.5%

Gross Margin

94.91%

N/A

Market Cap

$1.53B

N/A

Market Cap/Employee

$3.86M

N/A

Employees

395

N/A

Net Income

-$37.61M

+8.6%

EBITDA

-$29.77M

+10.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$238.07M

+11.3%

Total Debt

$208.26M

+34.3%

Accounts Receivable

$82.84M

+78.3%

Inventory

$22.75M

-4.3%

Long Term Debt

$206.75M

+34.4%

Short Term Debt

$1.51M

+16.0%

Return on Assets

-11.51%

N/A

Return on Invested Capital

-9.48%

N/A

Free Cash Flow

-$32.31M

+16.7%

Operating Cash Flow

-$32.24M

+16.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MAZEMaze Therapeutics, Inc.
$26.67+0.98%
NTLAIntellia Therapeutics, Inc.
$15.50+1.64%
ZYMEZymeworks Inc.
$24.30+1.76%
STOKStoke Therapeutics, Inc.
$30.39-2.31%

Trending Stocks

Symbol / CompanyPricePrice Chg
WENWendy's
$7.86+0.26%
AALAmerican Airlines Group
$17.44+0.08%
SOFISoFi Technologies
$17.31+0.00%
NOKNokia
$13.81+0.01%

Questions About ARDX

What is the current price of Ardelyx?

Ardelyx is trading at $6.19 per share.

What is the 52-week range for Ardelyx?

Over the past 52 weeks, Ardelyx has traded between $3.56 and $8.40.

How much debt does Ardelyx have?

As of the most recent reporting period, Ardelyx reported total debt of $208.26M.

How much cash does Ardelyx have on hand?

Ardelyx reported $31.21M in cash and cash equivalents in its most recent financial results.

What is Ardelyx’s dividend yield?

Ardelyx does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.